Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells

Virology Journal

Volumn 10, Issue , 2013, Pages

  Chen, Chiachen ^a,b   Akerstrom, Victoria ^a,b   Baus, James ^a,b   Lan, Michael S ^a,b,c   Breslin, Mary B ^a,b,c  

^a The Research Institute for Children at Children's Hospital New Orleans   (United States)

^b Diana Helis Henry Medical Research Foundation   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Lung cancer; NSCLC; SCLC; VSV G pseudotyped lentivirus

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CANCER GENE THERAPY; COMPARATIVE STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NONHUMAN; PROTEIN EXPRESSION; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

CELL LINE, TUMOR; DEPENDOVIRUS; GENETIC THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

ADENO-ASSOCIATED VIRUS; LENTIVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 84874939280     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-86     Document Type: Article

References (25)

1. Refining prognosis in non-small-cell lung cancer. Singh T, Dhindsa J, N Engl J Med 2007 356 190 author reply 190-1 17225287 (Pubitemid 46089686)
2. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. Jemal A, Thun MJ, Ries LA, J Natl Cancer Inst 2008 100 1672 94 10.1093/jnci/djn389 19033571
3. Latest development in viral vectors for gene therapy. Lundstrom K, Trends Biotechnol 2003 21 117 22 10.1016/S0167-7799(02)00042-2 12628368 (Pubitemid 36293768)
4. Gene therapy: twenty-first century medicine. Verma IM, Weitzman MD, Annu Rev Biochem 2005 74 711 38 10.1146/annurev.biochem.74.050304.091637 15952901 (Pubitemid 40995522)
5. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector. Hutson TH, Verhaagen J, Yanez-Munoz RJ, Gene Ther 2012 19 49 60 10.1038/gt.2011.71 21562590
6. AAV vector delivery to cells in culture. Smith A, Collaco R, Trempe JP, Methods Mol Biol 2004 246 167 77 14970591
7. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Zincarelli C, Soltys S, Rengo G, Mol Ther 2008 16 1073 80 10.1038/mt.2008.76 18414476 (Pubitemid 351737072)
8. AAV hybrid serotypes: improved vectors for gene delivery. Choi VW, McCarty DM, Samulski RJ, Curr Gene Ther 2005 5 299 310 10.2174/1566523054064968 15975007 (Pubitemid 40895014)
9. Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system. McFarland NR, Lee JS, Hyman BT, J Neurochem 2009 109 838 45 10.1111/j.1471-4159.2009.06010.x 19250335
10. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector. Rohr UP, Wulf MA, Stahn S, Cancer Gene Ther 2003 10 898 906 10.1038/sj.cgt.7700643 14712316 (Pubitemid 37532336)
11. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. Zabner J, Seiler M, Walters R, J Virol 2000 74 3852 8 10.1128/JVI.74.8.3852-3858.2000 10729159 (Pubitemid 30180327)
12. Enhancing rAAV vector expression in the lung. Virella-Lowell I, Zusman B, Foust K, J Gene Med 2005 7 842 50 10.1002/jgm.759 15838934 (Pubitemid 41015532)
13. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Liu J, Saghizadeh M, Tuli SS, Mol Vis 2008 14 2087 96 19023450
14. Targeting retroviral and lentiviral vectors. Sandrin V, Russell SJ, Cosset FL, Curr Top Microbiol Immunol 2003 281 137 78 10.1007/978-3-642-19012-4- 4 12932077 (Pubitemid 36950685)
15. Viral vectors for gene delivery to the nervous system. Davidson BL, Breakefield XO, Nat Rev Neurosci 2003 4 353 64 10.1038/nrn1104 12728263 (Pubitemid 37280174)
16. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications. Farley DC, Iqball S, Smith JC, J Gene Med 2007 9 345 56 10.1002/jgm.1022 17366519 (Pubitemid 46796580)
17. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. Rutledge EA, Halbert CL, Russell DW, J Virol 1998 72 309 19 9420229 (Pubitemid 28048842)
18. Adeno-associated virus expression systems for gene transfer. Rabinowitz JE, Samulski J, Curr Opin Biotechnol 1998 9 470 5 10.1016/S0958-1669(98)80031-1 9821274 (Pubitemid 28478967)
19. Unique biologic properties of recombinant AAV1 transduction in polarized human airway epithelia. Yan Z, Lei-Butters DC, Liu X, J Biol Chem 2006 281 29684 92 10.1074/jbc.M604099200 16899463 (Pubitemid 44536977)
20. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy. Wu JQ, Zhao WH, Li Y, Virology 2007 368 309 16 10.1016/j.virol.2007.07.006 17675129 (Pubitemid 350016226)
21. Receptor targeting of adeno-associated virus vectors. Buning H, Ried MU, Perabo L, Gene Ther 2003 10 1142 51 10.1038/sj.gt.3301976 12833123 (Pubitemid 36896589)
22. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. Kaludov N, Brown KE, Walters RW, J Virol 2001 75 6884 93 10.1128/JVI.75.15.6884-6893.2001 11435568 (Pubitemid 32641575)
23. The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. Akache B, Grimm D, Pandey K, J Virol 2006 80 9831 6 10.1128/JVI.00878-06 16973587 (Pubitemid 44435657)
24. Distinctive gene transduction efficiencies of commonly used viral vectors in the retina. Zhang SH, Wu JH, Wu XB, Curr Eye Res 2008 33 81 90 10.1080/02713680701799408 18214745 (Pubitemid 351156946)
25. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Shi J, Zheng D, Liu Y, Cancer Res 2005 65 1687 92 10.1158/0008-5472.CAN-04-2749 15753363 (Pubitemid 40478593)